Roles of Bim in apoptosis of normal and Bcr-Abl-expressing hematopoietic progenitors

Molecular and Cellular Biology
R KuribaraT Inaba

Abstract

Bcr-Abl kinase is known to reverse apoptosis of cytokine-dependent cells due to cytokine deprivation, although it has been controversial whether chronic myeloid leukemia (CML) progenitors have the potential to survive under conditions in which there are limited amounts of cytokines. Here we demonstrate that early hematopoietic progenitors (Sca-1(+) c-Kit(+) Lin(-)) isolated from normal mice rapidly undergo apoptosis in the absence of cytokines. In these cells, the expression of Bim, a proapoptotic relative of Bcl-2 which plays a key role in the cytokine-mediated survival system, is induced. In contrast, those cells isolated from our previously established CML model mice resist apoptosis in cytokine-free medium without the induction of Bim expression, and these effects are reversed by the Abl-specific kinase inhibitor imatinib mesylate. In addition, the expression levels of Bim are uniformly low in cell lines established from patients in the blast crisis phase of CML, and imatinib induced Bim in these cells. Moreover, small interfering RNA that reduces the expression level of Bim effectively rescues CML cells from apoptosis caused by imatinib. These findings suggest that Bim plays an important role in the apoptosis of early hema...Continue Reading

References

Oct 1, 1992·The Journal of Experimental Medicine·M K CollinsA Lopez-Rivas
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·G Q Daley, D Baltimore
Jun 14, 1996·Biochemical and Biophysical Research Communications·H HondaH Mano
Aug 9, 1996·The Journal of Biological Chemistry·S M KingK K Pfister
May 19, 1997·Biochemical and Biophysical Research Communications·H HondaH Hirai
Feb 28, 1998·The EMBO Journal·L O'ConnorD C Huang
May 23, 1998·Annual Review of Immunology·D T Chao, S J Korsmeyer
Sep 12, 1998·Science·J M Adams, S Cory
Feb 20, 2003·Proceedings of the National Academy of Sciences of the United States of America·Kui Lei, Roger J Davis
Apr 18, 2003·Cell Death and Differentiation·L CoultasA Strasser
Jul 5, 2003·Nature Cell Biology·Mauricio J ReginatoJoan S Brugge
Jul 10, 2003·Blood Cells, Molecules & Diseases·Kiyotaka KawauchiShin ichiro Ohkawa

❮ Previous
Next ❯

Citations

Oct 11, 2008·Cell Death and Differentiation·K Balmanno, S J Cook
Apr 16, 2011·Leukemia·L S SteelmanJ A McCubrey
Apr 7, 2012·Nature Medicine·Emily H Cheng, Charles L Sawyers
Feb 19, 2005·Nature Reviews. Immunology·Andreas Strasser
Jun 10, 2006·Cell Death and Differentiation·L D Walensky
Feb 27, 2007·Oncogene·J M Adams, S Cory
Jul 28, 2006·Cold Spring Harbor Symposia on Quantitative Biology·J M AdamsS Cory
Dec 7, 2011·Cancer Discovery·Anthony C FaberJeffrey A Engelman
Jul 2, 2010·The Journal of Clinical Investigation·Danilo PerrottiTomasz Skorski
Jan 21, 2011·BMC Cancer·Joëlle RubertThomas Radimerski
Nov 16, 2004·International Journal of Hematology·Toshiya Inaba
Aug 4, 2012·Critical Reviews in Eukaryotic Gene Expression·Hisashi Harada, Steven Grant
Sep 26, 2006·Proceedings of the National Academy of Sciences of the United States of America·Junya KurodaAndreas Strasser
May 17, 2014·Apoptosis : an International Journal on Programmed Cell Death·Yaqiong DongChengrong Lu
Mar 19, 2014·ISRN Oncology·Ewelina TrelaJanusz Błasiak
Sep 24, 2011·Advances in Hematology·Flora TzifiAndreas Scorilas
Apr 29, 2006·Cell Death and Differentiation·V LabiA Villunger
Jul 17, 2015·Biotechnic & Histochemistry : Official Publication of the Biological Stain Commission·B Vesela, E Matalova
Jan 30, 2016·Nature Reviews. Cancer·Alex R D DelbridgeDavid L Vaux
Aug 19, 2015·Biochimica Et Biophysica Acta·Saverio CandidoJames A McCubrey
Nov 3, 2012·Trends in Cell Biology·Maria Maryanovich, Atan Gross
Nov 15, 2011·Cancer Letters·Jeffrey J RodvoldMaurizio Zanetti
Dec 15, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Raquel T LimaM Helena Vasconcelos
Apr 11, 2009·Biochemical and Biophysical Research Communications·Hiroya AsouToshiya Inaba
May 1, 2009·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Edurne San José-EnerizJose Roman-Gomez

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis